Manuel-Carreon Maristela MD Merced, CA - 95340

Manuel-Carreon Maristela MD is categorized under Nonclassified Establishments in Merced, CA and active since 2007.

Manuel-Carreon Maristela MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Nonclassified Establishments business, which does work in the BOTH market, and is classified as a Nonclassified Establishments, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Maristela Manuel-Carreon at the company’s single location by writing to 410 East Yosemite Avenue # A, Merced, California CA 95340 or by phoning (209) 384-9108. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Manuel-Carreon Maristela MD
Contact Person: Maristela Manuel-Carreon
Address: 410 East Yosemite Avenue # A, Merced, California 95340
Phone Number: (209) 384-9108
Annual Revenue (USD): $500.000 to $999.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Nonclassified Establishments
SIC Code: 9999
NAICS Code: 6211110
Share This Business:

Manuel-Carreon Maristela MD was started in 2007 to provide professional Nonclassified Establishments under the SIC code 9999 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Maristela Manuel-Carreon for inquiries that concern Manuel-Carreon Maristela MD by calling the company number (209) 384-9108, as your correspondence is most welcome. Additionally, the physical location of the single location of Manuel-Carreon Maristela MD can be found at the coordinates 37.33207,-120.46247 as well as the street address 410 East Yosemite Avenue # A in Merced, California 95340.

For its online presence, you may visit Manuel-Carreon Maristela MD’s website at and engage with its social media outlets through on Twitter and on Facebook.